Elevance Health · Multi-Quarter Financial Trends

16 quarters · As reported by the company · Amounts in USD billions← ELV

Quarter	Period End	Revenue ($B)	YoY	Gross Margin	Operating Income ($B)	Net Income ($B)	Net Margin	Free Cash Flow ($B)	EPS	Buybacks ($B)	Dividends ($B)
FY2026 Q2	2026-06-30	50.47	+1.4%	89.1%	1.76	1.46	2.9%	1.63	6.71	0.23	0.37
FY2026 Q1	2026-03-31	50.18	+2.6%	89.1%	2.09	1.76	3.5%	4.10	8.00	1.12	0.38
FY2025 Q4	2025-12-31	49.75	+9.5%	88.9%	0.31	0.55	1.1%	-0.21	2.56	0.47	0.38
FY2025 Q3	2025-09-30	50.71	+12.4%	89.4%	1.30	1.19	2.3%	0.78	5.32	0.88	0.38
FY2025 Q2	2025-06-30	49.78	+13.4%	89.4%	2.43	1.74	3.5%	1.79	7.72	0.38	0.39
FY2025 Q1	2025-03-31	48.89	+14.8%	89.8%	3.17	2.18	4.5%	0.82	9.61	0.88	0.39
FY2024 Q4	2024-12-31	45.44	+6.6%	86.8%	0.67	0.42	0.9%	0.38	1.88	1.81	0.37
FY2024 Q3	2024-09-30	45.11	+5.3%	88.7%	1.41	1.02	2.3%	2.35	4.36	0.06	0.39
FY2024 Q2	2024-06-30	43.89	+0.5%	89.0%	2.77	2.30	5.2%	0.12	9.85	0.46	0.38
FY2024 Q1	2024-03-31	42.58	+1.0%	91.0%	3.02	2.25	5.3%	1.70	9.59	0.57	0.38
FY2023 Q4	2023-12-31	42.65	+6.8%	88.7%	1.28	0.86	2.0%	-3.30	3.68	0.93	0.35
FY2023 Q3	2023-09-30	42.85	+7.3%	89.2%	1.76	1.29	3.0%	2.29	5.45	0.48	0.35
FY2023 Q2	2023-06-30	43.67	—	90.1%	2.63	1.85	4.2%	1.60	7.79	0.65	0.35
FY2023 Q1	2023-03-31	42.17	—	91.7%	2.83	1.99	4.7%	6.17	8.30	0.62	0.35
FY2022 Q4	2022-12-31	39.93	—	90.9%	1.26	0.87	2.2%	-1.82	3.61	0.57	0.31
FY2022 Q3	2022-09-30	39.94	—	91.4%	2.25	1.60	4.0%	4.62	6.62	0.58	0.31

Quarterly figures come from the company's 10-Q and 10-K filings. The fourth quarter is derived as the full year minus the first three quarters; cash flow items are converted from fiscal year-to-date totals into single quarters.